Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma

Overview of attention for article published in Journal of Hematology & Oncology, January 2018

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 171 Dimensions

Readers on

mendeley: 58 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 171 publications that cite this research output.

171

The most recent citing publications are shown below. View all 171 publications that cite this research output on Dimensions.

Optimization of immune checkpoint inhibitor treatment planning for relapsed or refractory extranodal NK/T cell lymphoma

Article in Annals of Hematology (May 2024)

Counterproductive effects of anti-CD38 and checkpoint inhibitor for the treatment of NK/T cell lymphoma

Article in Frontiers in Immunology (April 2024)

Real-world multicenter study of PD-1 blockade in HIV-associated classical Hodgkin lymphoma across the United States

Article in Clinical Lymphoma Myeloma & Leukemia (April 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.